Corealis Pharma has acquired a new 33,000-sq.-ft. pharmaceutical research facility in the Cité de la Biotech in Laval, Quebec, Canada. The company is hiring highly skilled scientists and purchasing complementary analytical and manufacturing equipments. These investments are part of Corealis’ ongoing strategic development plan to be recognized as “the reference in oral solid dosage formulation development,” according to a company statement. Dr. Yves Roy, president of Corealis...